Vimarsana
Biggest News Aggregation in the World

Page 4 - Feb 15 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Feb 15. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Feb 15 Today - Breaking & Trending Today

Groundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP) - Vimarsana News

Groundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP)

Putting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301. MELBOURNE, Australia, Feb. 15, 2023 /PRNewswire/ -- In collaboration with US-based Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and The Royal Adelaide Hospital, leading Australian CRO, Accelagen, is proud to announce that dosing has commenced in the Phase 1 first-in-human trial for KIO-301. This trial represents a remarkable development in the treatment of people with the rare inherited condition, Retinitis Pigmentosa (RP), which currently has no approved cure or standar...

American Standard Unveils New Brand Identity To Create Homes That People Will Love Everyday - Vimarsana News

American Standard Unveils New Brand Identity To Create Homes That People Will Love Everyday

Love where you live, no matter who or where you are - LIFE. LOVE. HOME BANGKOK, Feb. 15, 2023 /PRNewswire/ -- American Standard, one of the most iconic brands in sanitary ware and part of LIXIL, maker of pioneering water and housing products, today unveiled a new global brand identity. The American Standard brand has grown phenomenally across the world. The new brand identity brings together brand nuances over time into a unified brand expression of empathy and closeness to consumers, together with a new brand claim of LIFE. LOVE. HOME. In the Asia Pacific region, this milestone was celebrated...

GILEAD TO PRESENT DATA AT APASL 2023 ON EFFECTIVE MODELS FOR MONITORING AND TREATING HEPATITIS C AND EFFICACY OF ANTIVIRAL TREATMENTS FOR HIV-1 AND HBV-COINFECTED ADULTS - Vimarsana News

GILEAD TO PRESENT DATA AT APASL 2023 ON EFFECTIVE MODELS FOR MONITORING AND TREATING HEPATITIS C AND EFFICACY OF ANTIVIRAL TREATMENTS FOR HIV-1 AND HBV-COINFECTED ADULTS

- Study recommends a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus (HCV) infection with DAA Therapies - Review of implementation science projects toward HCV Elimination by 2030 in Asia proved effective in improving patient outcomes - Efficacy and safety demonstrated with Bictegravir/Emtricitabine/Tenofovir Alafenamide as compared to Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate as initial treatment in HIV-1/HBV-Coinfected adults SINGAPORE, Feb. 15, 2023 /PRNewswire/ -- Gilead Sciences Inc. today announced data from multiple stud...

The Skanner News - Get Immunizations Updated Before School Exclusion Day Feb. 15 - Vimarsana News

The Skanner News - Get Immunizations Updated Before School Exclusion Day Feb. 15

The third Wednesday of February (Feb. 15) is School Exclusion Day, and the Oregon Immunization Program reminds parents that children may not be able to attend school or child care that day if their records show missing immunizations.

Cliff Eberhardt, John Gorka, Lucy Kaplansky, Patty Larkin in Reunion Tour at Strand, Feb. 15 - Vimarsana News

Cliff Eberhardt, John Gorka, Lucy Kaplansky, Patty Larkin in Reunion Tour at Strand, Feb. 15

ROCKLAND — Folk singer-songwriters Cliff Eberhardt, John Gorka, Lucy Kaplansky, and Patty Larkin will stop at the Strand Theatre on their “On A Winter’s Night” Reunion Tour on Wednesday, Feb. 15, at 7:30 p.m. “Eberhardt, Gorka, Kaplansky, and Larkin...